The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Restasis is an effective treatment for
preventing the occurrence and progression of dry eye syndrome in patients who have recently
received a bone marrow transplant and are at risk to graft-versus-host disease.